BOULDER, Colo., Oct. 1, 2001 (PRIMEZONE) -- Hauser, Inc. (OTCBB:HAUS) announced today it has exercised its option to purchase patented technology and the intellectual property rights related to policosanol, a product derived from beeswax. In clinical studies, policosanol has demonstrated benefits for promoting healthy cholesterol levels. Hauser licensed the patented technology from a developmental start-up company. Terms were not disclosed.
As part of this transaction, Hauser acquired the rights to U.S. Patent No. 6,225,354, which covers the manufacturing, composition and use of policosanol.
"Products containing policosanol are an excellent alternative for those looking to maintain healthy cholesterol levels," said Kenneth Cleveland, Hauser president and chief executive officer. "Our branded Apisol(tm) and Policor(tm) policosanol products are manufactured using the highest quality beeswax, a GRAS approved (generally recognized as safe) raw material."
Hauser, a Customer Connected(SM) company headquartered in Boulder, Colo., is a leading supplier of herbal extracts and nutritional supplements. The company also provides interdisciplinary laboratory testing services, chemical engineering services and contract research and development. The company's products and services are principally marketed to the pharmaceutical, dietary supplement and food ingredient businesses. Hauser's business units include: Botanicals International Extracts, Hauser Laboratories, Shuster Laboratories and ZetaPharm.
Certain oral and written statements of management of the Company included in this Press Release and elsewhere may contain forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. These statements include the plans and objectives of management for future operations. The forward-looking statements included herein and elsewhere are based on current expectations that involve judgments which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking statements will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements, the inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved.